Standard BioTools Inc. - Common Stock (LAB)
0.9846
+0.0246 (2.56%)
NASDAQ · Last Trade: Mar 22nd, 9:08 AM EDT

Relay Therapeutics develops precision medicines targeting oncology and genetic diseases, leveraging proprietary computational technology.
Via The Motley Fool · February 27, 2026

This clinical-stage biotech develops oral therapies for chronic diseases, with a lead candidate targeting type-2 diabetes and obesity.
Via The Motley Fool · February 27, 2026
Standard BioTools Inc (NASDAQ:LAB) Surges on Strong Q4 Earnings Beatchartmill.com
Via Chartmill · February 24, 2026
Via Benzinga · November 18, 2025

Standard BioTools just reported results for the second quarter of 2024.
Via InvestorPlace · July 31, 2024
Via Benzinga · June 25, 2025
Illumina will acquire SomaLogic to expand in proteomics, adding new revenue streams and accelerating tech development in multiomics.
Via Benzinga · June 23, 2025
Via Benzinga · June 23, 2025
There are notable gap-ups and gap-downs in today's session. Let's take a look at which stocks are gapping on Monday.
Via Chartmill · June 23, 2025

Standard BioTools just reported results for the first quarter of 2024.
Via InvestorPlace · May 8, 2024

Via Benzinga · January 13, 2025

Via Benzinga · August 27, 2024

Via Benzinga · August 19, 2024

Via Benzinga · August 12, 2024

Via Benzinga · August 2, 2024

Via Benzinga · August 1, 2024

Via Benzinga · August 1, 2024

Via Benzinga · May 23, 2024

Via Benzinga · May 20, 2024

The Dow Jones index closed higher by around 75 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
Via Benzinga · March 7, 2024

Via Benzinga · October 4, 2023
